Effects of Hyperlipidemia on Plasma Sodium, Potassium, and Chloride Measurements by an Indirect IonSelective Electrode Measuring System
To the Editor:
We used indirect ion-selective electrode (ISE) methods (Roche/Hitachi Modular) to investigate the effect of hyperlipidemia (cholesterol plus triglycerides) on measurements of sodium, potassium, and chloride and the ability of published formulas to correct for the decrease in measured Na ϩ , K ϩ , and Cl Ϫ . As recommended by Kroll (1 ), we did not use enriched samples but instead used 21 patient samples (lithium-heparin plasma and serum) with triglyceride concentrations Ͼ15 mmol/L, total lipid concentrations (cholesterol plus triglycerides; Roche/Hitachi Modular) Ͼ20 mmol/L, a lipemic index (Modular) Ͼ3, and a total protein concentration within the reference interval (62-83 g/L). We analyzed samples before and after ultracentrifugation (Airfuge; Beckman Coulter; 15 min at 107 000g) by indirect ISE potentiometry (Modular) and direct ISE (Rapidlab 865; Bayer).
The ultracentrifuged indirect ISE result (y) and nonultracentrifuged direct ISE result (z) were subtracted from the nonultracentrifuged indirect ISE result (x; see Fig. 1 in the Data Supplement that appears with the online version of this letter at http://www.clinchem.org/content/ vol52/issue1/).
The lipid concentration varied inversely, not only with Na ϩ but also with Cl Ϫ and (to a lesser degree) K ϩ concentrations, as measured by the indirect ISE system (see Fig. 1 
In a second set of 24 hyperlipidemic patient samples, analyzed prospectively, we observed effects of total lipids similar to those seen in the first set; we also demonstrated the utility of the formulas derived from the first set ( Table 1) .
The published formula by IonescuTirgoviste and Cheta (2 ) leads to overestimation of the decrease in sodium. The Steffes-Freier formula (3 ) is based on triglyceride concentration alone; thus, there is potential for error in cases in which the hyperlipidemia is caused predominantly by hypercholesterolemia or mixed hypertriglyceridemia/hypercholesterolemia. In samples from patients with confirmed hypercholesterolemia, electrolytes should be measured with a direct ISE system.
The new formulas are simpler than published ones and allow operators to perform the calculations promptly. Thus, laboratories not equipped with computers, direct ISE systems, Airfuges, or lipid-clearing agents can estimate the true electrolyte concentrations. Care must be taken, however, if hyperlipidemia is complicated by hypoproteinemia or hyperproteinemia (4 ).
In our organization, we have adopted a standardized approach to the processing of hyperlipidemic samples. We visually check turbid samples to determine whether it is possible to see through the sample. If not, the sample is analyzed for cholesterol, triglycerides, and lipemic index, and these results are reported irrespective of whether a lipid profile is requested. Triglycerides or cholesterol Ͼ20 mmol/L on first presentation are critical for proper patient management and are promptly phoned to the clinical unit. In cases in which the lipemic index is Ն3, the sample is optically turbid, and the total lipid concentration is Ͼ25 Table 1 . Differences observed with the recommended and our correction formulas for decreases in the indirect ISE electrolytes with increasing total lipid concentration in the second subset of samples.
Analyte and correction formula a Difference, mean (SD) To the Editor: Cell-free fetal nucleic acids (cffDNA) are present in maternal plasma and serum (1 ), but amniotic fluid (AF) also provides an attractive source of cffDNA. The concentration of cffDNA is 100-to 200-fold higher in AF than in maternal plasma/serum (2 ), but low yields of cffDNA compromise testing by techniques such as genomic microarrays, which require a minimum of 100 ng of DNA (3 ).
For protocol optimization, we used 5 large-volume AF supernatant samples from patients who had undergone therapeutic amnioreduction for twin-twin transfusion syndrome. After optimization, we compared the DNA yield of the old and new protocols for freshly discarded AF supernatant samples from 29 euploid singleton pregnancies. Approval for this study was obtained from the Institutional Review Boards of Tufts-New England Medical Center and Women and Infant's Hospital. The median gestational age at amniocentesis was 16.9 weeks (25th-75th percentiles, 16.4 -18.1 weeks).
We changed our original method (3 ) in the following 3 ways: we increased the vacuum extraction pressure to 800 mbar; we replaced the volume-overloaded mini spin columns with maxi spin columns (Qiagen) to allow for larger starting volumes; and we replaced the QiaAmp Lysis (AL) buffer with proprietary QiaAmp Viral Lysis (AVL) buffer (Qiagen), which has a high chaotropic salt concentration, on the basis of the similarities of AF and urine, a body fluid for which AVL buffer is recommended.
Quantitative PCR analysis of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) locus was performed in triplicate for each sample (4 ), with the mean result of the 3 reactions used for further calculations. The results were expressed as genome equivalents (GE) per milliliter, using a conversion factor of 6.6 pg of DNA per cell (5 ).
For large-volume AF samples, replacing AL with AVL buffer (using mini columns with high vacuum) led to a mean (SD) DNA yield of 1470 (456) GE/mL, and replacing mini with maxi columns (using AL buffer) led to a mean DNA yield of 1564 (623) GE/mL. Finally, substituting AL with AVL buffer and replacing mini with maxi columns led to a mean DNA yield of 1972 (786) GE/mL. DNA extraction with phenol, chloroform, and isoamyl alcohol (6 ) did not further improve the yield from 1 large-volume AF sample.
For euploid singleton pregnancies (n ϭ 29), the median amount of GAPDH DNA extracted from 10 mL of AF with the new protocol was 1700 GE/mL (25th-75th percentiles, 1071-4938 GE/mL) compared with 246 (93-524) GE/mL obtained with the original protocol (3 ) (P Ͻ0.0001, Wilcoxon signed-rank test). The proportion of samples that had a sufficient yield of extracted DNA for subsequent chromosome microarray analysis (i.e., Ն100 ng) also increased compared with the original protocol, from 39% (28 of 72) (3 ) to 86% (25 of 29; P Ͻ0.0001, 2 test). The new protocol allowed extraction of cffDNA from Յ10 samples in less than 3 h. The replacement of AL with AVL buffer eliminated the need for a heating bath during the lysis step, and fewer overall steps are involved in the protocol, which may reduce the potential for contamination. The cost of reagents and supplies for cffDNA extraction from a 10-mL AF supernatant sample is ϳ10-fold higher for the new
